Atorvastatin calcium price December 2025 and outlook (see chart below)
- India:US$97.4/KG, 3.8% up
Business Analytiq assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, or timeliness.
NEED A QUICK DOWNLOAD?
ACCESS TO OUR FULL DATABASE IS US$399/YEAR, WITH A 30-DAY $50 TRIAL
GET THAT DOWNLOAD IN 3 MINUTES!
BusinessAnalytiq provides a database of hundreds of market & price trend data, as well as online tools to set up benchmarks and leading indicators.
Atorvastatin calcium price index
This post is a summary of the Atorvastatin calcium price developments. The price developments of Atorvastatin calcium are expressed in US$ prices converted FX rates applicable at the time when the price was valid. Atorvastatin calcium price index developments are calculated from multiple separate sources of data to ensure statistical accuracy.
The outlook for Atorvastatin calcium prices is generated from different inputs including:
- Very recent price developments of immediate cost drivers of Atorvastatin calcium prices
- Recent price developments of underlying feedstocks which drive the price of Atorvastatin calcium
- Market futures for both cost drives and feedstocks of Atorvastatin calcium prices
- Adjustment of current supply/demand imbalances in the Atorvastatin calcium market
- Longer term trends in likely demand conditions
What is Atorvastatin calcium and what is it used for
Atorvastatin calcium is the calcium salt form of atorvastatin, a member of the statin family of drugs. It competitively inhibits HMG-CoA reductase (the rate-limiting enzyme in cholesterol synthesis), lowering LDL-cholesterol and triglycerides and modestly raising HDL. It is prescribed (with diet and lifestyle changes) to treat hypercholesterolaemia and to reduce the risk of cardiovascular events such as heart attack and stroke in people at elevated risk.
How is Atorvastatin calcium produced
Atorvastatin calcium is manufactured by multi-step chemical synthesis to produce the atorvastatin active moiety and then converted to its calcium salt (often isolated as a crystalline or amorphous trihydrate). Commercial routes use protected intermediates, boronate or lactone intermediates and controlled hydrolysis/neutralization steps; several improved, scale-up processes and patents describe solvent/anti-solvent crystallizations, formation of the calcium salt and purification steps used for large-scale API manufacture. Final finished products are formulated into tablets by conventional pharmaceutical tableting processes.
How large is the global market for Atorvastatin calcium and where is it produced
Market estimates vary by report and by whether the figure covers the branded drug, generics or specifically the atorvastatin-calcium API. Recent market reports place the wider atorvastatin drug market in the multi-billion USD range (business-research estimates ~US$11–13 billion for broader atorvastatin products), while dedicated atorvastatin-calcium market reports (API/finished-salt focused) typically report values in the hundreds of millions and project mid-single-digit to high single-digit CAGRs over the 2020s. Different methodologies and scope (branded Lipitor® vs generic atorvastatin calcium API vs finished-dose products) explain the spread between reports.
Production of atorvastatin APIs and finished atorvastatin-calcium tablets is global. A large share of generic API manufacture is concentrated in established pharmaceutical API hubs (notably India and China), with many contract and proprietary API producers listed in supplier databases. Finished-dose manufacturing occurs worldwide (India, China, Europe, North America and others), and major generic and innovator companies (and many smaller contract manufacturers) supply regional and global markets. Supply-chain reports and supplier directories list dozens of atorvastatin/atorvastatin-calcium API manufacturers and exporters.